Gila Therapeutics

Gila Topical Lingual Neural Signaling enables delivery of natural peptide hormones with the goal of activating targeted areas of the brain directly implicated in regulating metabolism.

Gila’s lead program is Topical Lingual PYY. The company is pursuing Phase II proof of concept studies under an active IND in the US and additional mechanistic clinical trials OUS.